TAPBP

protein-coding

TAP binding protein, the group of C1-set domain containing

Gene summary

This gene encodes a transmembrane glycoprotein which mediates interaction between newly assembled major histocompatibility complex (MHC) class I molecules and the transporter associated with antigen processing (TAP), which is required for the transport of antigenic peptides across the endoplasmic reticulum membrane. This interaction is essential for optimal peptide loading on the MHC class I molecule. Up to four complexes of MHC class I and this protein may be bound to a single TAP molecule. This protein contains a C-terminal double-lysine motif (KKKAE) known to maintain membrane proteins in the endoplasmic reticulum. This gene lies within the major histocompatibility complex on chromosome 6. Alternative splicing results in three transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]

MANE transcript

NM_003190.5

Inheritance

AR

ClinVar variants

P:3U:233B:113

Top phenotype

MHC class I deficiency 3

gnomAD constraint

pLI —, LoF o/e 0.77

Max pathogenic AF

—

Genomic locus

chr6:33,299,694-33,314,284

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~14.6 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

MHC class I deficiency 1MODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0971006

Submitter: PanelApp Australia

MHC class I deficiencyLIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0011476

Submitter: Ambry Genetics

MHC class I deficiencyLIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0011476

Submitter: Labcorp Genetics (formerly Invitae)

MHC class I deficiencySUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0011476

Submitter: Orphanet

MHC class I deficiencyMODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0011476

Submitter: ClinGen

A TAPBP germline loss of function variant was first identified in a woman with type I bare lymphocyte syndrome (BLS) (PMID: 12149238), the only report of a germline TAPBP variant. Other somatic TAPBP variants have been identified in cancers. Autosomal recessive TAPBP deficiency was associated with reduction of class I MHC expression and reductions in CD8 T cell and NK cell numbers in peripheral blood. Herpes zoster infection was noted in this adult patient, but no other immune deficiency was noted. This phenotype contrasts with type I BLS due to biallelic loss of function variants in TAP1, where patients show respiratory inflammation and skin ulcers. The indel variant identified in the single patient resulted in the loss of exon 4-7 of TAPBP, resulting in loss of expression of the protein and loss of function. Heterozygous carriers have not been reported in the literature. TAPBP plays a critical role in the peptide loading and resultant stable expression of cell surface MHC class I. In vitro data show that TAPBP is found in a complex with TAP1, TAP2, MHC, ERp57, and calreticulin, and is required for expression of class I MHC on the surface of cell lines (PMID: 9271576). Studies of cancer cell lines have found that variants in TAPBP reduce the expression of MHC class I on the surface of cells, potentially as a mechanism of immune evasion (PMID: 26381407). Class I MHC expression in these cell lines can be rescued with the transfection of WT TAPBP (PMID: 26381407). TAPBP knockout mice recapitulate the phenotype seen in the reported patient, with loss of stable class I MHC expression and reduced CD8 T cells (PMID:10973281, 12594855). TAPBP KO mice also show alterations in NK cell function and the ability of dendritic cells to cross-present antigens (PMID:10973281). TAPBP heterozygous KO mice show normal expression of MHC I (PMID: 10973281). While there is no evidence against the gene-disease relationship of TAPBP and type I BLS, there was only one patient identified that supports the relationship. Based on this,TAPBP has limited association with type I bare lymphocyte deficiency. This classification was originally approved by the ClinGen SCID-CID GCEP on 10/20/2022 (SOP Version 9). It was re-evaluated on June 19th, 2025 with no additional cases identified. Therefore, there is no change in this gene disease relationship.

Clinical Genomic Database (CGD)

MHC class I deficiency 3AR

Manifestation: Allergy/Immunology/Infectious

Intervention: Allergy/Immunology/Infectious

Rationale: Although the described individual did not have the same types of infections as other individuals with TAP deficiency, antiinfectious prophylaxis and early and aggressive treatment of infections may be beneficial

Refs: 10074495; 12149238Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to TAPBP variants in ClinVar

7 Conditions Cataloged
MHC class I deficiencyTotal: 350
not specifiedTotal: 70
not providedTotal: 12
TAPBP-related disorderTotal: 11
MHC class I deficiency 1Total: 3
MHC class I deficiency 3Total: 2
Kartagener syndromeTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_003190.5. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
3
clinvar
93
clinvar
6
clinvar
102
missense
195
clinvar
13
clinvar
1
clinvar
209
nonsense
1
clinvar
7
clinvar
8
start loss
1
clinvar
1
frameshift
2
clinvar
15
clinvar
17
splice donor/acceptor (+/-2bp)
12
clinvar
12
Total032331067349

Highest pathogenic variant AF is 0.00018970485

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 50 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_003190.5RefSeqNP_003181.38MANE Select
ENST00000434618.7EnsemblENSP00000395701.28MANE Select
NM_001410875.1RefSeqNP_001397804.17Standard
NM_172208.3RefSeqNP_757345.27Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Antigen processing and presentation - Homo sapiens (human)
  • Immune System
  • Adaptive Immune System
  • Antigen processing-Cross presentation
  • Class I MHC mediated antigen processing & presentation

Biological Process

  • MHC class Ib protein complex assembly
  • antigen processing and presentation of peptide antigen via MHC class I
  • antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent
  • retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum
  • immune response

Molecular Function

  • protein binding
  • peptide antigen-transporting ATPase activity
  • MHC class I protein binding
  • peptide antigen binding
  • TAP1 binding

Cellular Component

  • Golgi membrane
  • endoplasmic reticulum
  • endoplasmic reticulum membrane
  • integral component of membrane
  • phagocytic vesicle membrane

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000426633
Coding exons
7
Length
14694
Individuals with no LoFs
125637
Homozygous LoFs
1
Heterozygous LoFs
110
Defined
125748
p
0.000441
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.7642582950.8750.00001543156
Missense (PolyPhen)8197.3120.832371081
Synonymous0.9771131270.8900.000006771144
Loss of Function0.9491519.50.7680.00000105182

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000380.00037rare
Latino/Admixed American0.000780.00075rare
Ashkenazi Jewish00.0absent
East Asian0.000110.00011rare
Finnish0.0000520.000046rare
European (Non-Finnish)0.000610.00058rare
South Asian0.000260.00026rare
Other0.000330.00033rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Involved in the association of MHC class I with transporter associated with antigen processing (TAP) and in the assembly of MHC class I with peptide (peptide loading). {ECO:0000269|PubMed:10636848}.;
Disease
DISEASE: Bare lymphocyte syndrome 1 (BLS1) [MIM:604571]: A HLA class I deficiency. Contrary to bare lymphocyte syndromes type 2 and type 3, which are characterized by early-onset severe combined immunodeficiency, class I antigen deficiencies are not accompanied by particular pathologic manifestations during the first years of life. Systemic infections have not been described. Chronic bacterial infections, often beginning in the first decade of life, are restricted to the respiratory tract. {ECO:0000269|PubMed:12149238}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Intolerance Scores

LoFtool
0.977
RVIS EVS
0.13
RVIS percentile EVS
63.49

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.992

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.